Development of Malaysia breast cancer survival prognostic tool (myBeST) for prediction of survival probability among women with breast cancer in Malaysia

Kadir, Mohd Nasrullah Nik Ab. (2023) Development of Malaysia breast cancer survival prognostic tool (myBeST) for prediction of survival probability among women with breast cancer in Malaysia. Masters thesis, Universiti Sains Malaysia.

PDF - Submitted Version
Download (1MB) | Preview


Background: Breast cancer accounts for a sizeable portion of newly diagnosed cancer. Prognostic tools were developed to inform patients regarding their outcomes. Performance of Western-centric tools found to be less accurate when applied in our setting with PREDICT breast cancer (PREDICT) had an acceptable accuracy. Objective: The study aimed to develop predictive models for survival among women with breast cancer in Malaysia, to compare its performance with PREDICT and the model’s algorithm was incorporated to develop a web-based Malaysian Breast Cancer Survival Prognostic Tool (myBeST). Methodology: This study consists of two phases. Phase 1 is a retrospective cohort study using data abstracted from seven regional breast cancer referral centres in Malaysia. We collected 13 predictors and survival outcomes. Time-to-event Cox proportional hazard (PH) analysis and two supervised machine learning classifiers (decision tree (DT) and artificial neural networks (ANN)) were employed to model and predict five-year survival probability. The model with the best performance indices was compared with the PREDICT tool. Subsequently, in Phase 2, the model was deployed in a web-based format with accompanying content to describe the tool. The website underwent several user-centred iterative development stages, including content (n = 8) and face validity (n = 20) assessments by medical specialists and medical officers. Results: There were 1,006 patients included for model derivation and validation. They were mostly Malay, with ductal carcinoma, hormone-sensitive, HER2-negative, at T2, N1-stage, without metastasis, received surgery and chemotherapy. The five-year survival was 60.5% (95% CI: 57.6, 63.6). By the Cox PH model, Indians had a higher hazard of death compared to Malay (Adjusted HR (Adj. HR): 1.77, 95% CI: 1.19, 2.63). Histological type, cancer grade, tumour, node, and metastasis stage at diagnosis significantly associated with death. Those who received surgery (Adj. HR: 0.49, 95% CI: 0.28, 0.87), chemotherapy (Adj. HR: 0.59, 95% CI: 0.44, 0.79), and radiotherapy (Adj. HR: 0.70, 95% CI: 0.51, 0.96) had a lower risk of death. Cox PH model outperformed the DT and ANN model in terms of accuracy (Cox PH: 0.841, DT: 0.811, ANN: 0.821), F1-score (Cox PH: 0.879, DT: 0.859, ANN: 0.870) and the area under the receiver operating characteristic curve (AUC; Cox PH: 0.891, DT: 0.39, ANN: 0.877). The Cox PH was more accurate in predicting five-year survival probability with a higher AUC (0.78, 95% CI: 0.73, 0.82) than PREDICT (AUC: 0.75, 95% CI 0.70, 0.80). Thus, the model was deployed as the main feature of our webbased prognostic tool. The website was developed and improved at every iterative stage. The content validity indices were ≥0.88 and face validity indices were >0.90, resulting in a functioning and user-centred prognostic tool. Conclusion: The web-based tool derived from robust Cox PH model showed promising results. Further validation, usability, and feasibility studies are necessary as the tool could potentially be used by care providers to convey individualised survival prediction for newly diagnosed breast cancer patients.

Item Type: Thesis (Masters)
Uncontrolled Keywords: breast neoplasm, predictive model, survival analysis, prognostic tool, Malaysian women
Subjects: R Medicine > RC Internal medicine > RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Kampus Kesihatan (Health Campus) > Pusat Pengajian Sains Perubatan (School of Medical Sciences) > Thesis
Depositing User: Mr Abdul Hadi Mohammad
Date Deposited: 09 Aug 2023 06:56
Last Modified: 24 Apr 2024 05:56

Actions (login required)

View Item View Item